Reconvalescent Plasma/camostat Mesylate in Early SARS-CoV-2 Q-PCR Positive High-risk Individuals (RES-Q-HR): a Structured Summary of a Study Protocol for a Randomized Controlled Trial

by Verena Keitel-Anselmino, Winfried V. Kern, Christian Ohmann, Study group RES-Q-HR Trial Team · 2021

Book is in your Library